Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 7/20 | 0.53 |
| ▸ | MEN1 | O00255 | 2/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.51 |
| ▸ | ASAH1 | Q13510 | 1/20 | 0.51 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.46 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.45 |
| ▸ | NAAA | Q02083 | 1/20 | 0.45 |
| ▸ | DEGS1 | O15121 | 1/20 | 0.45 |
| ▸ | CASP2 | P42575 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7914686 | 1.00 | FAAH (0.53) | FAAHMEN1KMT2AASAH1MAPK1 | |
| SCHEMBL28417284 | 1.00 | FAAH (0.53) | FAAHMEN1KMT2AASAH1MAPK1 | |
| SCHEMBL22575879 | 1.00 | FAAH (0.53) | FAAHMEN1KMT2AASAH1MAPK1 | |
| SCHEMBL31472777 | 1.00 | FAAH (0.53) | FAAHMEN1KMT2AASAH1MAPK1 | |
| SCHEMBL12359197 | 1.00 | FAAH (0.53) | FAAHMEN1KMT2AASAH1MAPK1 | |
| SCHEMBL31472778 | 1.00 | FAAH (0.53) | FAAHMEN1KMT2AASAH1MAPK1 | |
| SCHEMBL18992757 | 0.98 | FAAH (0.50) | FAAHMEN1KMT2AASAH1MAPK1 | |
| SCHEMBL28446577 | 0.98 | FAAH (0.50) | FAAHMEN1KMT2AASAH1MAPK1 | |
| SCHEMBL22467337 | 0.93 | KDM4E (0.46) | FAAHMEN1KMT2AASAH1NAAA | |
| SCHEMBL15057658 | 0.93 | KDM4E (0.46) | FAAHMEN1KMT2AASAH1NAAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230304960-A1 | SENSOR FOR MEASURING IONIZED MAGNESIUM | INSTRUMENTATION LABORATORY COMPANY | 2023-09-28 | — | — | US | disclosed |
| WO-2023154326-A1 | SENSOR FOR MEASURING IONIZED MAGNESIUM | INSTRUMENTATION LABORATORY COMPANY (US) | 2023-08-17 | — | — | WO | disclosed |
| EP-3694324-A1 | ACTIVE INGREDIENT COMPOSITIONS COMPRISING N-ALKENOYL-N-ALKYLGLUCAMIDES AND THE USE THEREOF | Clariant International Ltd (CH) | 2020-08-19 | — | — | EP | disclosed |
| WO-2019072804-A1 | ACTIVE INGREDIENT COMPOSITIONS COMPRISING N-ALKENOYL-N-ALKYLGLUCAMIDES AND THE USE THEREOF | CLARIANT INTERNATIONAL LTD (CH) | 2019-04-18 | — | — | WO | disclosed |
| US-20170339949-A1 | SUGAR SURFACTANTS AND USE THEREOF IN AGROCHEMICAL COMPOSITIONS | CLARIANT INTERNATIONAL LTD. (CH) | 2017-11-30 | — | — | US | disclosed |
| EP-2616476-A2 | SUBSTITUTED SACCHARIDE COMPOUNDS AND DENTAL COMPOSITIONS | 3M Innovative Properties Company (US) | 2013-07-24 | — | — | EP | disclosed |
| WO-2012036838-A2 | SUBSTITUTED SACCHARIDE COMPOUNDS AND DENTAL COMPOSITIONS | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2012-03-22 | — | — | WO | disclosed |
| EP-2316017-A1 | USE OF POLYOXYALKYLENE NONIONIC SURFACTANTS WITH MAGNESIUM ION SELECTIVE ELECTRODES | Siemens Healthcare Diagnostics Inc. (US) | 2011-05-04 | — | — | EP | disclosed |
| WO-2010021923-A1 | USE OF POLYOXYALKYLENE NONIONIC SURFACTANTS WITH MAGNESIUM ION SELECTIVE ELECTRODES | SIEMENS HEALTHCARE DIAGNOSTICS INC. (US) | 2010-02-25 | — | — | WO | disclosed |
| EP-2073782-A2 | DENTAL COMPOSITIONS INCLUDING ORGANOGELATORS, PRODUCTS, AND METHODS | 3M Innovative Properties Company (US) | 2009-07-01 | — | — | EP | disclosed |
| WO-2008033911-A2 | DENTAL COMPOSITIONS INCLUDING ORGANOGELATORS, PRODUCTS, AND METHODS | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2008-03-20 | — | — | WO | disclosed |
| US-7205290-B2 | Diphenylazetidinone with improved physiological properties, process for its preparation, medicaments comprising this compound, and its use | SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) | 2007-04-17 | — | — | US | disclosed |
| US-7205290-B2 | Diphenylazetidinone with improved physiological properties, process for its preparation, medicaments comprising this compound, and its use | SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) | 2007-04-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170339949-A1 | SUGAR SURFACTANTS AND USE THEREOF IN AGROCHEMICAL COMPOSITIONS | SGMS1, DEGS1, SGMS2 | FAAH 183/4885MEN1 2633/4885KMT2A 2459/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.